Skip to main content
OpenTrials

Clinical trial condition

Neurofibromatosis 2

Explore clinical trials studying Neurofibromatosis 2. Study availability and eligibility vary by location and protocol.

36 public trials 4 recruiting studies
Refine in advanced search Browse all conditions

Neurofibromatosis 2 trial results

Completed

Bevacizumab for Symptomatic Vestibular Schwannoma in Neurofibromatosis Type 2 (NF2)

NCT01207687

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cranial Nerve Diseases, Cranial Nerve Neoplasms, +29 more
Locations
  • Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States
  • National Cancer Institute Rockville, Maryland, United States
  • Massachusetts General Hospital Charlestown, Massachusetts, United States
View Trial Details
Completed

Phase II Trial of Sunitinib (SU011248) in Patients With Recurrent or Inoperable Meningioma

NCT00589784

Conditions
Brain Diseases, Brain Neoplasms, CNS Cancer, +42 more
Locations
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Memoral Sloan Kettering Cancer Center Basking Ridge, New Jersey, United States
  • Memorial Sloan-Kettering Cancer Center at Commack Commack, New York, United States
  • Memorial Sloan-Kettering Cancer Center New York, United States
View Trial Details

Related conditions